Liver function parameters in HIV/HCV co-infected patients treated with amprenavir and ritonavir and correlation with plasma levels.
Vincenzo Spagnuolo(IRCCS Ospedale San Raffaele), Elena Seminari(Policlinico San Matteo Fondazione), Laura Galli(Vita-Salute San Raffaele University), Gianluca Gentilini(Vita-Salute San Raffaele University), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Armando Soldarini(Vita-Salute San Raffaele University), Anna De Bona(Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo), Fernanda Dorigatti(Vita-Salute San Raffaele University)
PubMed
July 1, 2007
Cited by 9
Related Papers
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173
Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy
|New England Journal of Medicine|2001|168
Cardiovascular risk and dyslipidemia among persons living with HIV: a review
|BMC Infectious Diseases|2017|152